Amalgam Rx
amalgamrx.com
Artificial Intelligence
Biotechnology
Health Care
As featured in
Claim pageClaim
Follow
Overview
Connections
News
Salaries
Products
People
Growth
Offices
Financials
Visa sponsorship
2 ▲ 100%
H-1B filings in 12 months
$78k
Median offered salary
0
Open roles in United States
Who they sponsor
Data scientists
1
Web and digital interface designers
1
In the register as Amalgam RX, Inc., Wilmington, DE
Other sponsors in the same field
PharmaforceIQ 
OmniScience 
ClearNote Health 
Gatc Health
Alert me
US Department of Labor · latest filing Jun 16, 2026 · Visa details by country
News
Amalgam Rx Wins "Overall Large Language Model of the Year"
June 25, 2026, WILMINGTON, DE (BUSINESS WIRE) - AI Breakthrough, a leading market intelligence organization that recognizes the top companies, technologies, and products in the global Artificial Intelligence (AI) market, today announced that Amalgam Rx, I
Read more
Report
Marking National Colorectal Cancer Awareness Month, Privia Health Program Achieves 84% Colorectal Cancer Screening Rate Through Industry Collaboration
March 03, 2026, WILMINGTON, DE (BUSINESS WIRE) - Amalgam Rx, Inc., a leader in data-driven, AI-powered healthcare engagement and clinical decision support, today announced results from a Privia Health (NASDAQ: PRVA)-led colorectal cancer (CRC) screening p
Read more
Report
Amalgam Rx's Medical-Grade AI Doubles Digital Health Engagement-Validated in Peer-Reviewed Studies.
WILMINGTON, Del., October 21, 2025--Amalgam Rx, Inc., a leader in AI-powered healthcare decision-making, announced the publication of two peer-reviewed research papers validating its Medical-Grade AI framework---a clinically governed system delivering saf
Read more
Report
Amalgam Rx's Clinical AI Doubles Digital Health Engagement-Validated in Peer-Reviewed Studies
WILMINGTON, DE - (BUSINESS WIRE) - Amalgam Rx, Inc., a leader in AI-powered healthcare decision-making, announced the publication of two peer-reviewed research papers validating its clinical AI technology-a clinically governed system delivering safe and h
Read more
Report
Amalgam Rx Partners with Biolinq - Lighting Pathways to Better Health
WILMINGTON, DE - (BUSINESS WIRE) - Amalgam Rx, Inc., a leading provider of software for regulated medical devices, powered by their Medical-Grade Al technology, announced its collaboration with Biolinq Incorporated in developing the digital backbone for B
Read more
Report
Amalgam Rx: $20 Million Credit Investment Raised From Catalio
Amalgam Rx announced a $20 million credit investment from Catalio Capital Management to expand its Medical-Grade AI solutions for healthcare.
Read more
Report
Amalgam Rx Secures $20M Credit Investment from Catalio Capital Management to Accelerate Clinical AI Deployment
WILMINGTON, DE - (BUSINESS WIRE) - Amalgam Rx, Inc., a leader in enabling data-driven healthcare decision making, today announced a $20 million credit investment from Catalio Capital Management, a leading investment firm dedicated to backing innovative he
Read more
Report
Amalgam Rx Secures $20M Credit Investment from Catalio Capital Management to Accelerate Medical-Grade AI Deployment
WILMINGTON, Del., August 12, 2025--Amalgam Rx, Inc., a leader in enabling data-driven healthcare decision making, today announced a $20 million credit investment from Catalio Capital Management, a leading investment firm dedicated to backing innovative he
Read more
Report
Amalgam Rx Secures $20M to Accelerate AI-Powered Healthcare Solutions
Amalgam Rx, a company specializing in data-driven healthcare decision-making, has announced a $20M credit investment from Catalio Capital
Read more
Report
Show more news
People
Ryan Sysko
Executive Officer, Director
Sarwar Islam
Director
Sonny Vu
Director
Jeffrey Courtney
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Wilmington
United States
HQ
50-200 est. staff
Financials
Total raised
$27.3M
Latest round
Venture - Series Unknown
Funding rounds
5